Reduced effective population size in an overexploited population of the Nile crocodile (Crocodylus niloticus)

Unchecked exploitation of wildlife resources is one of the major factors influencing species persistence throughout the world today. A significant consequence of exploitation is the increasing rate at which genetic diversity is lost as populations decline. Recent studies suggest that life history traits affecting population growth, particularly in long-lived species, may act to moderate the impact of population decline on genetic variation and lead to remnant populations that appear genetically diverse despite having passed through substantial demographic bottlenecks. In this study we show that the retention of genetic variation in a partially recovered population of Nile crocodile is deceptive, as it masks the reality of a significant decline in the population’s effective size (N_e). Repeated episodes of unchecked hunting in the mid to late 20th century have today led to a five-fold decrease in the population’s N_e. Using current census data we estimate the contemporary N_e/N ratio as 0.05 and, in light of quotas that permit the ongoing removal of adults, simulated the likely effects of genetic drift on extant levels of variation. Results indicate that even if the current effective size is maintained, both allelic diversity and heterozygosity will decline. Our findings have complex implications for long-lived species; an emphasis on the retention of genetic variation alone, whilst disregarding the effects of population decline on effective size, may ultimately obscure the continued decline and extinction of exploited populations.     

Monensin controlled-release intraruminal capsule for control of bloat in pastured dairy cows

Monensin, a polyether ionophore antibiotic, is potentially an important agent for bloat relief in dairy cows grazing temperate legume-based pasture. A series of studies was undertaken to determine the effect of monensin, when delivered continuously in the rumen of lactating dairy cows by means of controlled-release capsules (monensin CRC). Such devices release approximately 300 mg/head/day for 100 d. A short-term pilot study made at Ruakura, New Zealand, tested monensin CRC in cows selected for high susceptibility to bloat and grazing lucerne (Medicago sativa) or red clover (Trifolium pratense). Treatment significantly reduced the incidence of bloat, while milk yield and protein yield were increased. There was no effect on fat yield. Following the pilot study, 6 large-scale field experiments involving a total of 368 lactating dairy cows, were made in Australia and New Zealand to confirm the effectiveness of monensin CRC for bloat control and to measure the effect of such treatment on milk production and composition. A severe bloat problem occurred in 2 experiments, mild bloat occurred in 2 others, while no visual signs of bloat were observed in the remaining 2 experiments. Bloat was significantly (P less than 0.05) reduced by monensin CRC treatment when data was pooled over the 4 experiments in which bloat occurred. Daily milk yield was increased in all experiments from a mean of 17.7 in untreated groups to 18.8 kg/head/day (P less than 0.05) in monensin CRC-treated cows. Protein percentage was not affected by treatment, while there was a decrease from 4.29 to 4.10% fat, although total fat yield was not affected.(ABSTRACT TRUNCATED AT 250 WORDS)     

A longitudinal study of lymphocyte subsets in a cohort of cats naturally-infected with feline immunodeficiency virus

Despite the potential of feline immunodeficiency virus (FIV) as an animal model for human immunodeficiency virus (HIV) studies, the long term effects of naturally-occurring infection have not been determined. HIV infection causes an ongoing deterioration in immune function which directly correlates with disease, in particular acquired immunodefciency syndrome (AIDS). However, it is not known whether FIV-induced immunosuppression is progressive or related to the clinical condition. This study examined changes in lymphocyte subset numbers of serial samples, taken from cohorts of FIV-positive and FIV-negative cats over an 18-month period. FIV-positive cats were clinically staged as asymptomatic carriers (AC) or cats with AIDS-related complex (ARC), and FIV-negative cats matched and staged on the basis of similar diseases. During the course of the study, 4 FIV-positive cats developed AIDS, classed as the terminal stage of infection. There were no significant differences in the mean absolute numbers of any lymphocyte subset between the onset (to) and the completion (t18) of the study. Similarly there were no significant changes in subset numbers during the 18 months preceding the development of AIDS. While the study period was brief and the sample sizes small, it is postulated that FIV infection in Australia may not necessarily cause progressive immunodeficiency and that FIV-induced immunosuppression (as measured by subset analysis) may not be well correlated with the clinical status of the infected cat.     

Diversity among isolates of Actinobacillus equuli and related organisms as revealed by ribotyping

Objective The objective of this work was to examine the diversity within Australian isolates of Actinobacillus equuli and related organisms by the genotypic method of ribotyping.
Design Ribotyping, performed using the enzyme Hae III, was used to examine the diversity in 12 field isolates of A equuli (five being capable of fermenting L-arabinose), one field isolate of Pasteurella caballi and two unclassifiable field isolates. Isolates were obtained from Australian horses, except for three isolates of A equuli (one L-arabinose positive and two L-arabinose negative) which were obtained from horses and a pig in Africa. In addition, the type strains for A equuli and P caballi and a reference strain for Bisgaard Taxon 9 were included in the study.
Results The ribotype patterns were analysed by computerised cluster analysis, yielding five clusters (A to E). All five of the L-arabinose positive A equuli were assigned to cluster A, with all the other seven A equuli isolates (all L-arabinose negative) and the type strain being assigned to cluster B. One of the two unclassified isolates formed cluster C along with the reference strain for Bisgaard Taxon 9. The remaining unclassified isolate formed cluster D. Cluster E consisted of the field isolate and reference strain of P caballi .
Conclusion The results of this study indicate that A equuli is a diverse species, with L-arabinose positive isolates of A equuli being quite distinct from typical L-arabinose negative isolates. Ribotyping appears to be a useful tool in confirming the identity of A equuli -like organisms from horses.     

Free and HF-HO-extractable amino acids determined by high performance liquid chromatography in a loamy sand soil

Summary Amino acids were extracted from fertility plots of a loamy sand soil with 0.05 M HF-HCl and with a 10% ethanol solution (free amino acids) and analysed by reverse-phase high performance liquid chromatography (HPLC). The total quantities of amino-N compounds analysed were 4.4 g/g soil for the acid treatment and 22.6 g/g soil for the 10% ethanol extract. Glycine and glutamic acid were the most abundant of 15 amino-N compounds in the HF-HCl extracts, whereas glutamic acid and ornithine + NH⁺ ₄ were found in the highest concentration in the 10% ethanol extracts. The HF-HCI pretreatment is used to increase the efficiency of the extraction of soil organic matter. Although this pretreatment removed some amino acids, the acids extract less than 1% of the total amino-N content of the crude soil extracts. The pretreatment, therefore, was not overly destructive. Comparisons between the amino acids extracted from the fertility plots were not conclusive, except for glycine, which was greater in concentration in the higher fertilizer N plots of the same crop rotation.     

terraGIS – a web GIS for delivery of digital soil maps in cotton‐growing areas of Australia

Effective management of soil requires the spatial distribution of its various physical, chemical and hydrological properties. This is because properties, for example clay content, determine the ability of soil to hold cations and retain water. However, data acquisition is labour intensive and time‐consuming. To add value to the limited soil data, remote sensing (e.g. airborne gamma‐ray spectrometry) and proximal sensing, such as electromagnetic (EM) induction, are being used as ancillary data. Here, we provide examples of developing Digital Soil Maps (DSM) of soil physical, chemical and hydrological properties, for seven cotton‐growing areas of southeastern Australia, by coupling soil data with remote and proximal sensed ancillary data. A greater challenge is how to get these DSM to a stakeholder in a way that is useful for practical soil use and management. This study describes how we facilitate access to the DSMs, using a simple‐to‐use web GIS platform, called terraGIS. The platform is underpinned by Google Maps API, which is an open‐source development environment for building spatially enabled Internet applications. In conclusion, we consider that terraGIS and the supporting information, available on the sister web page ( http://www.terragis.bees.unsw.edu.au/ ), allow easy access to explanation of DSM of soil properties, which are relevant to cotton growers, farm managers, consultants, extension staff, researchers, state and federal government agency personnel and policy analysts. Future work should be aimed at developing error budget maps to identify where additional soil and/or ancillary data is required to improve the accuracy of the DSMs.     

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

A domain of DNA designated N-myc is amplified 20- to 140-fold in human neuroblastoma cell lines but not in cell lines from other tumor types. N-myc has now been found to be amplified in neuroblastoma tissue from 24 of 63 untreated patients (38 percent). The extent of amplification appears to be bimodal, with amplification of 100- to 300-fold in 12 cases and 3- to 10-fold in 10 others. Amplification was found in 0 of 15 patients with stage 1 or 2 disease, whereas 24 of 48 cases (50 percent) with stage 3 or 4 had evidence of N-myc amplification. These data indicate that N-myc amplification is a common event in untreated human neuroblastomas. Furthermore, N-myc amplification is highly correlated with advanced stages of disease (P less than 0.001) and with the ability to grow in vitro as an established cell line, both of which are associated with a poor prognosis.     

Identifying crop yield gaps with site- and season-specific data-driven models of yield potential

Precision Agriculture - There is considerable interest and value in identifying the gap between crop yields that have actually been achieved, and yields that could have potentially been achieved. A...